People channel feed

Af­ter mul­ti­ple clin­i­cal tri­al fail­ures, Fi­bro­Gen lays off one-third of staff

Last year

ARCH-backed Im­muneID re­struc­tures and search­es for part­ners

Last year
Startups

Pieris Phar­ma­ceu­ti­cals lays off 70% of work­force af­ter As­traZeneca ends asth­ma med­i­cine part­ner­ship

Last year
Pharma

Neumo­ra goes big with three PhI­II de­pres­sion stud­ies, new CEO from Ab­b­Vie’s C-suite

Last year
R&D

FDA cites clean­ing, main­te­nance is­sues at Catal­ent fa­cil­i­ty re­spon­si­ble for Re­gen­eron’s drug re­jec­tion

Last year
FDA+
Manufacturing

Af­ter eject­ing out of Bris­tol My­ers R&D, Ru­pert Vessey lands at the top sci­ence post at a buzzy Flag­ship

Last year
Bioregnum

Avro­bio ends all de­vel­op­ment, search­es for life af­ter re­cent gene ther­a­py sale to No­var­tis

Last year
Cell/Gene Tx

BAKX Ther­a­peu­tics to shut down af­ter ‘sci­en­tif­ic chal­lenges’ and fi­nanc­ing dol­drums

Last year
Startups

Ei­sai’s US chair, glob­al Alzheimer’s leader to re­tire weeks af­ter Leqem­bi ap­proval

Last year

Jeff Leerink talks about why he's res­ur­rect­ing Leerink Part­ners af­ter buy­ing his firm back from bank­rupt SVB

Last year
Financing

Sum­it­o­mo will lay off 62 New York work­ers af­ter con­sol­i­dat­ing sev­en sub­sidiaries

Last year

Cal­i­for­nia Alzheimer's start­up True­Bind­ing rais­es more than $50M, lays off work­ers twice in June

Last year
Financing

Q&A: Fu­ji­film Diosynth’s new CEO Lars Pe­tersen talks pri­or­i­ties and plans for the CD­MO

Last year
Manufacturing

Gal­va­nize turns to lay­offs less than a year af­ter merg­ing three Ap­ple Tree com­pa­nies, rais­ing $100M

Last year
Startups

Ex­clu­sive: Saris­sa's board push drew lit­tle sup­port in Alk­er­mes share­hold­er vote

Last year

Sin­ga­pore can­cer cell ther­a­py start­up Tes­sa Ther­a­peu­tics to shut down

Last year
Cell/Gene Tx

Fol­low­ing con­tro­ver­sy, new Bio­gen di­rec­tor Su­san Langer won fewest votes from share­hold­ers

Last year

Cyteir to dis­solve as on­col­o­gy biotech scraps its fi­nal clin­i­cal at­tempt two years af­ter IPO

Last year
R&D

Bellerophon Ther­a­peu­tics lets al­most all em­ploy­ees go, looks for deals in wake of PhI­II flop

Last year

'Con­tin­ue lay­ing gold­en eggs!': Phar­ma ex­ec, doc­tors charged by SEC for al­leged in­sid­er trad­ing around Alex­ion-Por­to­la deal

Last year
Law

As it search­es for a new CEO, Il­lu­mi­na faces a high-stakes year of chal­lenges

Last year
R&D

Saris­sa and Alex Den­ner lose fight for board seats at Alk­er­mes

Last year

Fu­ji­film Diosynth names Lars Pe­tersen to re­place Mar­tin Mee­son as CEO

Last year
Manufacturing

Eiger Bio­Phar­ma­ceu­ti­cals to fo­cus on GLP-1 can­di­date, cut work­force by 25%

Last year
R&D
First page Previous page 23242526272829 Next page Last page
A service from the Financial Times